Cardiovascular Research Institute Maastricht (CARIM), The Netherlands.
J Hypertens. 2010 Feb;28(2):285-93. doi: 10.1097/HJH.0b013e3283330931.
Receptor for advanced glycation endproducts (RAGE)-ligand interaction may lead to vascular complications. Genetic variation in RAGE has been shown to alter expression, activity of RAGE or both. We, therefore, investigated whether RAGE single-nucleotide polymorphisms (SNPs) and haplotypes were associated with vascular disease.
Nine tag SNPs that cover the common RAGE gene variation were genotyped in 1291 individuals from two Dutch population-based cohort studies, aged 64.5 +/- 8.6 years, with normal glucose metabolism (44%), impaired glucose metabolism (23%) or type 2 diabetes mellitus (33%). We used multiple regression analyses to compare prevalent cardiovascular disease and markers of atherosclerosis, blood pressure and arterial stiffness across genotypes, and examine effect modification by glucose metabolism status.
In unstratified analyses, no consistent associations between RAGE SNPs and prevalent cardiovascular disease and markers of atherosclerosis were found. However, the AA genotype of SNP rs1800624 (-374T/A) was consistently associated with lower SBP [-5.0 mmHg (95% confidence interval -10.4 to 0.3)] and DBP [-4.2 (-7.2 to -1.3)], pulse pressure [-0.8 (-5.0 to 3.4)] as well as with less arterial stiffness [-0.56 SD (-1.04 to -0.09)] in individuals with normal glucose metabolism, but with higher SBP [6.2 (0.9-11.5)], DBP [2.1 (-0.7 to 5.0)] and pulse pressure [4.1 (-0.2 to 8.4)] in individuals with impaired glucose metabolism or type 2 diabetes mellitus (P for interaction <or=0.05 in all analyses). Similar results were found for a haplotype that includes the -374A allele.
In individuals with normal glucose metabolism, the -374A allele of the RAGE gene is protectively associated with blood pressure and arterial stiffness, whereas in individuals with impaired glucose metabolism or type 2 diabetes mellitus, it is adversely associated with these variables.
晚期糖基化终产物受体(RAGE)配体相互作用可能导致血管并发症。RAGE 的基因变异已显示出改变 RAGE 的表达、活性或两者兼而有之。因此,我们研究了 RAGE 单核苷酸多态性(SNP)和单倍型是否与血管疾病有关。
在两个荷兰基于人群的队列研究中,对 1291 名年龄为 64.5±8.6 岁、葡萄糖代谢正常(44%)、葡萄糖代谢受损(23%)或 2 型糖尿病(33%)的个体进行了 9 个标记 SNP 的基因分型,这些 SNP 涵盖了常见的 RAGE 基因变异。我们使用多元回归分析比较了不同基因型之间的心血管疾病和动脉粥样硬化标志物、血压和动脉僵硬度,并检查了葡萄糖代谢状态的效应修饰。
在未分层分析中,RAGE SNP 与心血管疾病和动脉粥样硬化标志物的患病率之间没有一致的关联。然而,SNP rs1800624(-374T/A)的 AA 基因型与正常葡萄糖代谢个体的 SBP[-5.0mmHg(95%置信区间-10.4 至 0.3)]和 DBP[-4.2(-7.2 至-1.3)]、脉压[-0.8(-5.0 至 3.4)]以及动脉僵硬度[-0.56SD(-1.04 至-0.09)]降低有关,但在葡萄糖代谢受损或 2 型糖尿病个体中,SBP[6.2(0.9-11.5)]、DBP[2.1(-0.7 至 5.0)]和脉压[4.1(-0.2 至 8.4)]较高(所有分析中 P 交互值均<0.05)。包含-374A 等位基因的单倍型也得到了类似的结果。
在葡萄糖代谢正常的个体中,RAGE 基因的-374A 等位基因与血压和动脉僵硬度呈保护性相关,而在葡萄糖代谢受损或 2 型糖尿病个体中,它与这些变量呈负相关。